Strl Biosystems Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 21.47 K
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 8450.99%
- Profit Growth 1354.12%
- Ebitda 1053.39%
- Net Worth 21961.86%
- Total Assets 7141.20%
About Strl Biosystems
Strl Biosystems Private Limited (SBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 12 October 2020 (Four years and three months 29 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 21.47 K , as per Ministry of Corporate Affairs (MCA) records.
Kalyan Kudikala and Akella Valli serve as directors at the Company.
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U33110TG2020PTC144740
-
Company No.
144740
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Oct 2020
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Strl Biosystems?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalyan Kudikala
|
Director | 12-Oct-2020 | Current |
|
Akella Valli
|
Director | 12-Oct-2020 | Current |
Financial Performance of Strl Biosystems.
Strl Biosystems Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 8450.99% increase. The company also saw a substantial improvement in profitability, with a 1354.12% increase in profit. The company's net worth Soared by an impressive increase of 21961.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Strl Biosystems?
In 2022, Strl Biosystems had a public holding of 6.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Hychem Sainor Chemicals Private LimitedKalyan Kudikala is a mutual person
-
Strlzymes Private Limited
Kalyan Kudikala and Akella Valli are mutual person
-
Kays Educational Services Private Limited
Kalyan Kudikala is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Strl Biosystems?
Strl Biosystems has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Strl Biosystems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Strl Biosystems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.